R. J. Bahde et al. / Tetrahedron Letters 52 (2011) 4103–4105
4105
References and notes
1. Goel, A.; Mazur, S. J.; Fattah, R. J.; Hartman, T. L.; Turpin, J. A.; Huang, M.; Rice,
W. G.; Appella, E.; Inman, J. K. Bioorg. Med. Chem. Lett. 2002, 12, 767–770.
2. Song, Y.; Goel, A.; Basrur, V.; Roberts, P. E. A.; Mikovits, J. A.; Inman, J. K.;
Turpin, J. A.; Rice, W. G.; Appella, E. Bioorg. Med. Chem. 2002, 10, 1263–1273.
3. Srivastava, P.; Schito, M.; Fattah, R. J.; Hara, T.; Hartman, T.; Buckheit, R. W.;
Turpin, J. A.; Inman, J. K.; Appella, E. Bioorg. Med. Chem. 2004, 12, 6437–6450.
4. Miller Jenkins, L.; Hara, T.; Durell, S. R.; Hayashi, R.; Inman, J. K.; Piquemal, J. P.;
Gresh, N.; Appella, E. J. Am. Chem. Soc. 2007, 129, 11067–11078.
5. Dorfman, T.; Luban, J.; Goff, S. P.; Haseltine, W. A.; Gottlinger, H. G. J. Virol. 1993,
67, 6159–6169.
6. (a) Housset, V.; De Rocquigny, H.; Roques, B. P.; Darlix, J. L. J. Virol. 1993, 67,
2537–2545; (b) Poon, D. T.; Wu, J.; Aldovini, A. J. Virol. 1996, 70, 6607–6616.
7. Wallace, G. S.; Cheng-Mayer, C.; Schito, M. L.; Fletcher, P.; Miller Jenkins, L. M.;
Hayashi, R.; Neurath, A. R.; Appella, E.; Shattock, R. J. J. Virol. 2009, 83, 9175–
9182.
Scheme 5. Variation of the ester coupling partner. Reagents and conditions: (i)
HBTU, i-Pr2EtN, b-ALA-NH2ÁHCl, DMF, rt; (ii) acid chloride (2 equiv), 2 h; (iii)
pentynoic acid, HBTU, 12 h.
8. The reported preparation is seven total steps with a longest linear sequence of
four steps.3 This route initiated from the disulfide dimer of 3; preparation and
isolation of the bis-N-hydroxysuccimide ester; coupling and isolation of the
diamide (such as 8, Scheme 2); disulfide cleavage; and final thioester
preparation plus a three step preparation of the free base of the aminoamide.
9. HBTU: O-benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate.
10. Rice, W. G.; Schaeffer, C. A.; Harten, B.; Villinger, F.; South, T. L.; Summers, M.
F.; Henderson, L. E.; Bess, J. W., Jr.; Arthur, L. O.; McDougal, J. S.; Orloff, S. L.;
Mendeleyev, J.; Kun, E. Nature 1993, 361, 473–475.
11. Rice, W. G.; Supko, J. G.; Malspeis, L.; Buckheit, R. W.; Clanton, D.; Bu, M.;
Graham, L.; Schaeffer, C. A.; Turpin, J. A.; Domagala, J.; Gogliotti, R.; Bader, J. P.;
Halliday, S. M.; Lori, C.; Sowder, R. C.; Arthur, L. O.; Henderson, L. E. Science
1995, 270, 1194–1197.
12. Domagala, J. M.; Bader, J. P.; Gogliotti, R. D.; Sanchez, J. P.; Stier, M. A.; Song, Y.;
Vara Prasad, J. V. N.; Tummino, P. J.; Scholten, J.; Harvey, P.; Holler, T.;
Gracheck, S.; Hupe, D.; Rice, W. G.; Schultz, R. Bioorg. Med. Chem. 1997, 5, 569–
579.
13. Loo, J. A.; Holler, T. P.; Sanchez, J.; Goliotti, R.; Maloney, L.; Reily, M. D. J. Med.
Chem. 1996, 39, 4313–4320.
14. Miller Jenkins, L. M.; Ott, D. E.; Hayashi, R.; Coren, L. V.; Wang, D.; Xu, Q.;
Schito, M. L.; Inman, J. K.; Appella, D. H.; Appella, E. Nat. Chem. Biol. 2010, 6,
887–889.
15. Villalobos, J. M.; Srogl, J.; Liebeskind, L. S. J. Am. Chem. Soc. 2007, 129, 15734–
15735.
Scheme 6. Variation of the amine coupling partner. Reagents and conditions: (i)
HBTU, i-Pr2EtN, AA-NH2ÁHCl, DMF, rt; (ii) (MeO)3Bz-Cl.
16. Liebeskind, L. S.; Yang, H.; Li, H. Angew. Chem., Int. Ed. 2009, 48, 1417–1421.
17. After dilution with EtOAc, CH2Cl2, and water, the reaction mixture was
submitted to vigorous stirring under air for 1 h. This exposure led to the
complete conversion of free thiol intermediate 7 into crystalline disulfide 8,
which precipitated from the mixture.
18. Taiyoung, S. J.; Russell, M. P.; Howard, J. Eur. Pat. Appl. EP 54936, 1982.
19. Jung, J.-C.; Kim, J.-C.; Park, O.-S. Synth. Commun. 2000, 30, 1193–1203.
20. Wurster, J. A.; Yee, R. C. Indol Kinase Inhibitors. U.S. Patent 7,439,371 B2,
October 21, 2008.
to cap the thiol (Scheme 6). These analogues were successfully pre-
pared using the standard condition and demonstrated that the
route tolerates steric congestion and
a-branching of the amine
component. The reactions proceeded uneventfully and provided
the desired analogues after purification.
The flexibility and efficiency of the synthetic route allows the
rapid preparation of new and unexplored SAMT analogues
(Schemes 5 and 6).23 Key aspects of this route, which allow facile
access to molecular diversity, include modularity, simple building
blocks, and lack of protecting group manipulation in a one-pot
reaction. Our new route and expanded library of SAMT structures
will be used to probe the pharmacology and structure–activity
relationships of the SAMTs as anti-HIV compounds. We will report
on the biological activity of these analogues in due course. This bio-
logical data will further our understanding of the acyl transfer and
aid in the design of a new generation of therapeutic molecules,
which are resistant to viral mutation.
21. Some reactions were purified by passing through a plug of silica gel prior to
recrystallization to remove HOBT esters. Complete experimental details are
reported in the Supplementary data.
22. One can envision a sequence of initial addition of multiple equivalents of HBTU
to the amine and 3, followed by subsequent addition of carboxylic acid to react
with the excess HBTU. In practice, we found that excess tetramethyluronium
coupling agent will react with the primary amine to provide the corresponding
tetramethylguanidine which was difficult to remove without silica gel
chromatography. This deleterious reactivity necessitates the sequential
addition of HBTU with the free acid after the initial amide formation is
complete.
23. Representative procedure for one-pot coupling. S-(2-((3-amino-3-
oxopropyl)carbamoyl)phenyl)3,4,5-trimethoxybenzothioate (5). Diisopropylethy-
lamine (36.0 mL, 204 mmol) was added to 2-mercaptobenzoic acid (9.00 g,
58.4 mmol), HBTU (23.2 g, 61.3 mmol), and b-alanine amide hydrochloride
(7.63 g, 61.3 mmol) in DMF (42.0 mL). The mixture slowly became
homogenous orange solution with stirring and maintained at rt for 12 h.
Addition of 3,4,5-trimethoxybenzoyl chloride (27.6 g, 120 mmol) gave
a
Acknowledgments
a
This research was supported in part by the Intramural Research
Program of the NIH, National Institute of Diabetes and Digestive
and Kidney Diseases. We thank Ettore Appella, and Lisa M. Miller
Jenkins (NIH, NCI) and Hans F. Luecke and Dongwook Kang (NIH,
NIDDK) for helpful discussion. We thank Noel Whittaker for able
assistance with Mass Spectral Analyses.
suspension. Rapid dissolution of the suspended material provided an orange
solution, which was followed by precipitation of an off white solid over the
course of 2 h. The mixture was diluted with CH2Cl2 (100 mL) and H2O (100 mL)
resulting in a biphasic mixture of two clear layers. The aqueous layer was
extracted with CH2Cl2 (4 Â 200 mL). The organic layers were combined, dried
(MgSO4), and concentrated under reduced pressure to furnish an orange oil. The
residue was redissolved in EtOAc (300 mL) and the solution was washed with
aqueous NaHCO3 (0.5 M, 100 mL) to remove trace DMF. The EtOAc layer was
chilled to 4 °C and the product crystallized to afford a white solid, S-2-(3-amino-
3-oxopropylcarbamoyl)phenyl 3,4,5-trimethoxybenzothioate (5) (17.0 g,
Supplementary data
40.6 mmol, 70% yield): mp 183 °C; 1H NMR (400 MHz, DMSO)
d 8.36 (t,
J = 5.4 Hz, 1H), 7.67–7.45 (m, 4H), 7.39–7.28 (m, 1H), 7.21 (s, 2H), 6.81 (s, 1H),
3.87 (s, 6H), 3.77 (s, 3H), 3.40–3.33 (m, 2H), 2.30 (t, J = 7.3 Hz, 2H); 13C NMR
(100 MHz, DMSO) d 187.8, 172.3, 167.0, 153.0, 142.4, 141.7, 136.6, 131.3, 129.8,
129.5, 128.1, 124.7, 104.4, 60.2, 56.1, 35.8, 34.8; IR (neat) 3421, 3338, 3244, 1677,
1662, 1633, 1584, 1414 cmÀ1; HRMS (ESI) m/z calcd for C20H23N2O6S [M+H]
419.1277, found 419.1267.
Supplementary data (general experimental methods and proce-
dures for the preparation of 5, 8, 11, 13, 15–18, 20–22, detailed char-
acterization data, and copies of the spectral data) associated with
this article can be found, in the online version, at doi:10.1016/